ClinicalTrials.Veeva

Menu

Lifestyles Of Health And Sustainability for Breast Cancer Survivors

W

Wonju Severance Christian Hospital

Status

Unknown

Conditions

Breast Cancer

Treatments

Behavioral: Combined aerobic and strength exercise training

Study type

Interventional

Funder types

Other

Identifiers

NCT02895178
LOHAS-BCS

Details and patient eligibility

About

The purpose of this study is to examine the effects of exercise program on health-related physical fitness and biomarkers among breast cancer survivors.

Full description

Patients and survivors of breast cancer present impaired physical fitness and various complications including acute and chronic pain, severe fatigue, limited range of motion, and bone loss attributable to anticancer treatments. Therefore, regular exercise during and following cancer treatments has been recommended to enhance physical capabilities and relieve side-effect severities, leading to an improved quality of life. Despite the known general benefits to patients with cancer, the effects of exercise on cancer-related biomarkers and their modulators remain unclear.

PRIMARY OBJECTIVES:

I. To determine whether a 12-week exercise intervention will improve components of health-related physical fitness by measuring cardiorespiratory fitness, muscular exercise capacity and flexibility in breast cancer survivors.

II. To determine whether a 12-week exercise intervention will improve risk parameters of metabolic disease by measuring changes in body composition, waist circumference, blood pressure, and circulating levels of glucose, insulin, lipids components and C-reactive protein in breast cancer survivors.

III. To determine whether a 12-week exercise intervention will conduce to changes of cancer-related biomarker by measuring in serum levels of dickkopf-related protein 1 (DKK1), secreted frizzled-related protein 1 (SFRP1), sclerostin, osteoprotegerin, osteopontin, growth differentiation factor 15 (GDF-15), insulin like growth factor 1 (IGF-1), and IGFBP-3 in breast cancer survivors.

IV. To determine whether a 12-week exercise intervention will result in a improvement in inflammatory cytokines and adipokines by measuring in serum levels of interleukin 1 beta (IL-1β), IL-10, IL-11, tumor necrosis factor alpha (TNFα), leptin and adiponectin in breast cancer survivors.

V. To determine whether a 12-week exercise intervention will conduce to changes of myokines by measuring in serum levels of brain-derived neurotrophic factor (BDNF), IL-8, IL-15, fatty acid-binding protein 3 (FABP3), leukemia inhibitory factor (LIF), follistatin, fractalkine, fibroblast growth factor 21 (FGF-21), osteonectin and irisin in breast cancer survivors.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Have diagnosed as a stage of I-III breast cancer
  • Have undergone a lumpectomy or mastectomy
  • Have completed neoadjuvant/adjuvant chemotherapy and able to initiate Exercise program
  • Nonsmokers (i.e., not smoking during previous 12 months)
  • Able to provide physician clearance to participate in exercise program for 12 weeks

Exclusion criteria

  • History of chronic disease including diabetes, uncontrolled hypertension or thyroid disease
  • Weight reduction >= 10% within past 6 months
  • Metastatic disease
  • Participate in more than 60 minutes of exercise per week in the past 6 months
  • Cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

60 participants in 3 patient groups

Exercise in breast cancer survivors
Experimental group
Description:
Combined aerobic and strength exercise training for 12 weeks under supervision
Treatment:
Behavioral: Combined aerobic and strength exercise training
No exercise in breast cancer survivors
No Intervention group
Description:
Lifestyle counseling and standard of care follow up for 12 weeks
Exercise in healthy subjects
Sham Comparator group
Description:
Age-matched healthy subjects. Combined aerobic and strength exercise training for 12 weeks under supervision
Treatment:
Behavioral: Combined aerobic and strength exercise training

Trial contacts and locations

1

Loading...

Central trial contact

Jae Seung Chang, Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems